- Home
- NARI vs VERA Comparison
NARI vs VERA Comparison
Compare NARI & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- VERA
- Stock Information
- Founded
- NARI 2011
- VERA 2016
- Country
- NARI United States
- VERA United States
- Employees
- NARI N/A
- VERA N/A
- Industry
- NARI Medical/Dental Instruments
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- NARI Health Care
- VERA Health Care
- Exchange
- NARI Nasdaq
- VERA Nasdaq
- Market Cap
- NARI 3.0B
- VERA 2.8B
- IPO Year
- NARI 2020
- VERA 2021
- Fundamental
- Price
- NARI $49.66
- VERA $48.31
- Analyst Decision
- NARI Buy
- VERA Strong Buy
- Analyst Count
- NARI 10
- VERA 9
- Target Price
- NARI $59.13
- VERA $59.22
- AVG Volume (30 Days)
- NARI 918.3K
- VERA 1.2M
- Earning Date
- NARI 10-28-2024
- VERA 11-07-2024
- Dividend Yield
- NARI N/A
- VERA N/A
- EPS Growth
- NARI N/A
- VERA N/A
- EPS
- NARI N/A
- VERA N/A
- Revenue
- NARI $574,498,000.00
- VERA N/A
- Revenue This Year
- NARI $24.59
- VERA N/A
- Revenue Next Year
- NARI $18.28
- VERA N/A
- P/E Ratio
- NARI N/A
- VERA N/A
- Revenue Growth
- NARI 22.41
- VERA N/A
- 52 Week Low
- NARI $36.73
- VERA $12.28
- 52 Week High
- NARI $67.13
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- NARI 53.46
- VERA 59.07
- Support Level
- NARI $47.96
- VERA $43.41
- Resistance Level
- NARI $52.59
- VERA $46.82
- Average True Range (ATR)
- NARI 2.13
- VERA 2.48
- MACD
- NARI -0.36
- VERA -0.18
- Stochastic Oscillator
- NARI 29.77
- VERA 59.78
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.